Roche Holding AG's Fiscal Year is From January To December - All Figures are in CHF, Billions.
The item "Total-Cashflows-From-Financing-Activities" stands at -8.28 Billion Swiss Francs for the trailing twelve months (TTM) period ending 06/30/2025, the lowest value since 12/31/2023.'
Regarding the One-Year-Change of the series, the current value constitutes an decrease of -7.29 Billion Swiss Francs compared to the value the year prior.
The 1 year change is -7.29 Billion Swiss Francs.
The 3 year change is 17.38 Billion Swiss Francs.
The 5 year change is 13.85 Billion Swiss Francs.
The 10 year change is -4.47 Billion Swiss Francs.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Total Cashflows From Financing Activities | 905,699,262,464.00 |
![]() | Johnson & Johnson - Total Cashflows From Financing Activities | 486,508,953,600.00 |
![]() | AbbVie Inc - Total Cashflows From Financing Activities | 399,570,305,024.00 |
![]() | AstraZeneca PLC - Total Cashflows From Financing Activities | 280,205,508,085.11 |
![]() | Novartis AG - Total Cashflows From Financing Activities | 255,096,620,580.91 |